Lexicon Pharmaceuticals, Inc. Stock Boerse Muenchen
Stocks
LX31
US5288723027
Biotechnology & Medical Research
|
Market Closed -
Boerse Muenchen
07:43:00 2021-12-30 EST
|
5-day change | 1st Jan Change | ||
| 3.710 EUR | +3.23% |
|
-.--% | -14.52% |
| Market Cap | 912M 795M 751M 682M 1.28B 87.53B 1.28B 9B 3.47B 44.5B 3.43B 3.35B 143B | P/E 2026 * |
-12.2x | P/E 2027 * | -10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 912M 795M 751M 682M 1.28B 87.53B 1.28B 9B 3.47B 44.5B 3.43B 3.35B 143B | EV / Sales 2026 * |
24x | EV / Sales 2027 * | 45.8x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | +3.23% | ||
| Current month | -14.52% | ||
| Current year | -14.52% |
| 5 years | 3.59 |  | 4.34 |
| 10 years | 0.89 | | 15.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 2024-07-07 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 2025-01-01 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 2025-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 2004-12-31 |
Ray Debbane
CHM | Chairman | 71 | 2012-02-26 |
| Director/Board Member | 67 | 2007-08-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.23% | -.--% | - | - | 912M | |
| -0.31% | +5.79% | +47.13% | +99.00% | 70.88B | |
| +0.39% | +2.06% | +39.38% | +78.27% | 62.49B | |
| +0.50% | +7.13% | +33.27% | +16.01% | 26.34B | |
| -3.21% | -7.27% | -17.10% | +356.10% | 26.21B | |
| -2.64% | -0.69% | -0.17% | -13.01% | 24.13B | |
| +0.71% | +8.03% | +25.03% | -12.74% | 20.72B | |
| -1.26% | -7.81% | +156.15% | +320.43% | 15.36B | |
| -0.22% | +3.99% | +45.54% | +172.46% | 14.46B | |
| +0.73% | +1.71% | -5.51% | +849.47% | 14.24B | |
| Average | -0.21% | +1.65% | +35.97% | +207.33% | 30.54B | |
| Weighted average by Cap. | -0.46% | +1.44% | +35.38% | +147.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.95M 33.09M 31.24M 28.37M 53.16M 3.64B 53.38M 374M 144M 1.85B 143M 139M 5.96B | 19.91M 17.36M 16.4M 14.89M 27.9M 1.91B 28.01M 196M 75.79M 971M 74.8M 73.14M 3.13B |
| Net income | -72.44M -63.17M -59.64M -54.16M -101M -6.95B -102M -714M -276M -3.53B -272M -266M -11.37B | -90.96M -79.32M -74.9M -68.01M -127M -8.73B -128M -897M -346M -4.44B -342M -334M -14.28B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
- LX31 Stock
Select your edition
All financial news and data tailored to specific country editions
